Channel Therapeutics Corp - Common Stock, par value $0.0001 per share (CHRO) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2024 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
CHRO
Shares outstanding
6,039,027
Price per share
$1.26
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
0
Total reported value
$0
Share change
-147,903
Value change
-$187,297
Number of holders
0
Price from insider filings
$1.26
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Channel Therapeutics Corp - Common Stock, par value $0.0001 per share (CHRO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Alexandra Wood (Canada) Inc. 9.5% $775,152 574,187 Alexandra Wood (Canada) Inc. 13 Dec 2024
Ikarian Capital, LLC 7.3% $595,146 440,849 Ikarian Capital, LLC 31 Dec 2024

As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of Channel Therapeutics Corp - Common Stock, par value $0.0001 per share (CHRO). This represents 0% of the company’s total 6,039,027 outstanding shares.

Institutional Holders of Channel Therapeutics Corp - Common Stock, par value $0.0001 per share (CHRO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 0 $0 -$187,297 $1.26 0
2025 Q2 147,903 $187,297 -$657,524 $1.26 5
2025 Q1 595,845 $846,098 +$821,760 $1.42 8
2024 Q4 25,012 $16,032 -$41,032 $0.64 4
2024 Q3 83,936 $59,603 -$230,716 $0.71 5
2024 Q2 219,945 $290,328 -$42,164 $1.32 5
2024 Q1 251,888 $659,947 +$659,947 $2.62 1